Enhancing autophagy in pre-diabetic patients has potential to prevent onset of diabetes

Published on July 21, 2014 at 3:03 AM · No Comments

Diabetes affects almost 400 million people worldwide. One of the hallmarks of this disease is a loss of pancreatic β cells, which secrete insulin. In many patients the reduction of β cells is associated an accumulation of a toxic form of a protein produced by β cells, known as islet amyloid polypeptide. There are no therapies or treatment available to restore the β cell populations or function.

Three new studies in Journal of Clinical Investigation identify a pathway that protects β cells from the toxic form of islet amyloid polypeptide. Using animal models, all three groups found that a functional autophagy system, which acts to degrade dysfunctional cellular components, prevents toxic accumulation of islet amyloid polypeptide. Animals that expressed the human form of islet amyloid polypeptide, but produced β cells that were autophagy deficient, developed overt diabetes.

In the accompanying Commentary, Dhananjay Gupta and Jack L. Leahy suggest that enhancing autophagy in pre-diabetic patients has potential to prevent or delay the onset of diabetes.

Posted in: Medical Science News | Medical Research News | Medical Condition News

Tags: , , , , ,

Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский | Svenska | Polski
Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
Light-activated diabetes drug: an interview with Dr David Hodson